Aureus Asset Management LLC Stake in Thermo Fisher Scientific INC Com (TMO) Has Lowered by $5.50 Million as Share Value Rose

January 20, 2018 - By marketbeat

Investors sentiment increased to 0.96 in 2017 Q3. Its up 0.05, from 0.91 in 2017Q2. It increased, as 51 investors sold TMO shares while 383 reduced holdings. 77 funds opened positions while 339 raised stakes. 333.20 million shares or 3.09% more from 323.23 million shares in 2017Q2 were reported. Natl Asset Mgmt Inc holds 0.1% in Thermo Fisher Scientific Inc. (NYSE:TMO) or 3,133 shares. Whalerock Point Prtn Ltd Liability Corporation reported 2,516 shares. Daiwa Grp, Japan-based fund reported 49,633 shares. Highland Cap Ltd Liability Corp holds 0.59% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO) for 39,060 shares. Orrstown Finance Services Inc has 0.04% invested in Thermo Fisher Scientific Inc. (NYSE:TMO). Bowen Hanes & Comm Inc invested 1.94% in Thermo Fisher Scientific Inc. (NYSE:TMO). Highbridge Capital Mgmt Ltd Llc owns 11,216 shares or 0.03% of their US portfolio. Consolidated Investment Group Limited Liability, a Colorado-based fund reported 25,015 shares. Veritable Ltd Partnership reported 18,692 shares or 0.07% of all its holdings. Voya Investment Limited Liability Corporation, a Georgia-based fund reported 149,450 shares. Manchester Capital Ltd Liability Corporation stated it has 7,585 shares. 33,801 are owned by Country Club Trust Na. Dupont Management reported 12,684 shares. 31,119 are owned by Grandfield & Dodd Ltd Com. Capital Research holds 1.05% or 18.43M shares in its portfolio.

Since August 2, 2017, it had 0 buys, and 7 sales for $18.71 million activity. Shine Daniel P sold 2,026 shares worth $366,645. HORNSTRA PETER E sold $721,091 worth of Thermo Fisher Scientific Inc. (NYSE:TMO) on Tuesday, September 5. 11,318 Thermo Fisher Scientific Inc. (NYSE:TMO) shares with value of $1.96M were sold by MANZI JIM P. 4,140 Thermo Fisher Scientific Inc. (NYSE:TMO) shares with value of $736,092 were sold by HOOGASIAN SETH H. 360 shares valued at $65,149 were sold by HARRIS C MARTIN on Wednesday, August 30. On Wednesday, August 2 the insider Herrema Gregory J. sold $5.28M.

Aureus Asset Management Llc decreased its stake in Thermo Fisher Scientific Inc Com (TMO) by 33.67% based on its latest 2017Q3 regulatory filing with the SEC. Aureus Asset Management Llc sold 29,101 shares as the company’s stock rose 8.13% with the market. The institutional investor held 57,321 shares of the industrial machinery and components company at the end of 2017Q3, valued at $10.85M, down from 86,422 at the end of the previous reported quarter. Aureus Asset Management Llc who had been investing in Thermo Fisher Scientific Inc Com for a number of months, seems to be less bullish one the $85.62 billion market cap company. The stock increased 0.52% or $1.1 during the last trading session, reaching $213.51. About 1.44M shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 15.57% since January 20, 2017 and is uptrending. It has underperformed by 1.13% the S&P500.

Analysts await Thermo Fisher Scientific Inc. (NYSE:TMO) to report earnings on January, 30. They expect $2.66 EPS, up 10.37 % or $0.25 from last year’s $2.41 per share. TMO’s profit will be $1.07 billion for 20.07 P/E if the $2.66 EPS becomes a reality. After $2.31 actual EPS reported by Thermo Fisher Scientific Inc. for the previous quarter, Wall Street now forecasts 15.15 % EPS growth.

More notable recent Thermo Fisher Scientific Inc. (NYSE:TMO) news were published by: which released: “Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday …” on January 05, 2018, also with their article: “Thermo Fisher Scientific Announces More Than 30 Orders for Ion GeneStudio S5 …” published on January 16, 2018, published: “Thermo Fisher – Fishing For Cash” on January 11, 2018. More interesting news about Thermo Fisher Scientific Inc. (NYSE:TMO) were released by: and their article: “Thermo Fisher Scientific Designs Flexible Manufacturing Site for Flexion …” published on January 11, 2018 as well as‘s news article titled: “Can Thermo Fisher’s (TMO) Product Portfolio Up Q4 Earnings?” with publication date: January 19, 2018.

Thermo Fisher Scientific Inc. (NYSE:TMO) Ratings Coverage

Among 18 analysts covering Thermo Fisher Scientific (NYSE:TMO), 17 have Buy rating, 0 Sell and 1 Hold. Therefore 94% are positive. Thermo Fisher Scientific has $230 highest and $140 lowest target. $198.44’s average target is -7.06% below currents $213.51 stock price. Thermo Fisher Scientific had 54 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was maintained by Barclays Capital on Monday, September 25 with “Buy”. As per Thursday, July 13, the company rating was maintained by Jefferies. The rating was maintained by Leerink Swann on Monday, December 4 with “Buy”. Cleveland downgraded Thermo Fisher Scientific Inc. (NYSE:TMO) on Friday, September 9 to “Neutral” rating. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Hold” rating given on Tuesday, August 22 by Jefferies. The rating was maintained by Cowen & Co with “Buy” on Friday, September 8. The company was initiated on Thursday, September 22 by JP Morgan. The rating was initiated by Argus Research with “Buy” on Tuesday, October 6. Mizuho maintained Thermo Fisher Scientific Inc. (NYSE:TMO) rating on Tuesday, May 3. Mizuho has “Buy” rating and $163 target. The firm earned “Hold” rating on Tuesday, June 6 by Jefferies.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: